Choroid plexus papilloma(CPP)is a rare,slow-growing,and typically benign brain tumor that predominantly affects children.CPP is characterized by well-defined circular or lobulated masses in the ventricles,leading to s...Choroid plexus papilloma(CPP)is a rare,slow-growing,and typically benign brain tumor that predominantly affects children.CPP is characterized by well-defined circular or lobulated masses in the ventricles,leading to symptoms related to increased intracranial pressure and hydrocephalus.CPP diagnosis relies on a combination of clinical presentation,imaging findings,and histological examination.The World Health Organization(WHO)classification categorizes choroid plexus tumors into CPP(Grade Ⅰ),atypical CPP(aCPP,Grade Ⅱ),and choroid plexus carcinoma(CPC,Grade Ⅲ).This article reviewed current diagnostics modalities and explored the emergence of new diagnostic methods for CPP.Research on molecular markers and genetic alterations associated with CPP is ongoing,and some potential markers have been identified.These results offered insights into potential therapeutic targets and personalized treatment approaches for CPP.Advancements in radiomics and liquid biopsy hold promise for improving diagnostic accuracy and monitoring treatment outcomes for choroid plexus tumors.Radiomics can provide quantitative data from imaging studies,whereas liquid biopsy can analyze tumor-derived genetic material and molecular markers from body fluids,such as cerebrospinal fluid(CSF)and blood.The rapidly evolving fields of molecular and genetic research and novel diagnostic methods require continuous updates and advancements before their application in clinical practice.We hope that these advancements will lead to earlier and more precise diagnoses,better treatment options,and improved outcomes in patients with CPP and other brain tumors.展开更多
文摘Choroid plexus papilloma(CPP)is a rare,slow-growing,and typically benign brain tumor that predominantly affects children.CPP is characterized by well-defined circular or lobulated masses in the ventricles,leading to symptoms related to increased intracranial pressure and hydrocephalus.CPP diagnosis relies on a combination of clinical presentation,imaging findings,and histological examination.The World Health Organization(WHO)classification categorizes choroid plexus tumors into CPP(Grade Ⅰ),atypical CPP(aCPP,Grade Ⅱ),and choroid plexus carcinoma(CPC,Grade Ⅲ).This article reviewed current diagnostics modalities and explored the emergence of new diagnostic methods for CPP.Research on molecular markers and genetic alterations associated with CPP is ongoing,and some potential markers have been identified.These results offered insights into potential therapeutic targets and personalized treatment approaches for CPP.Advancements in radiomics and liquid biopsy hold promise for improving diagnostic accuracy and monitoring treatment outcomes for choroid plexus tumors.Radiomics can provide quantitative data from imaging studies,whereas liquid biopsy can analyze tumor-derived genetic material and molecular markers from body fluids,such as cerebrospinal fluid(CSF)and blood.The rapidly evolving fields of molecular and genetic research and novel diagnostic methods require continuous updates and advancements before their application in clinical practice.We hope that these advancements will lead to earlier and more precise diagnoses,better treatment options,and improved outcomes in patients with CPP and other brain tumors.
